© 2021 MJH Life Sciences™ and Clinical Care Targeted Communications, LLC. All rights reserved.
Jalpa A. Doshi, PhD
Articles
Reducing Out-of-Pocket Cost Barriers to Specialty Drug Use Under Medicare Part D: Addressing the Problem of "Too Much Too Soon"
March 17, 2017
Article
Medicare claims analyses offer insight into how proposed policy changes would affect out-of-pocket prescription costs for Part D beneficiaries requiring specialty drugs.
Synchronized Prescription Refills and Medication Adherence: A Retrospective Claims Analysis
February 16, 2017
Article
A retrospective claims analysis showed that synchronized refill schedules were associated with better medication adherence among Medicare Advantage patients taking multiple maintenance medications.
High Cost Sharing and Specialty Drug Initiation Under Medicare Part D: A Case Study in Patients With Newly Diagnosed Chronic Myeloid Leukemia
March 18, 2016
Article
A Medicare claims analysis of patients newly diagnosed with chronic myeloid leukemia revealed that high cost sharing was associated with reduced and/or delayed tyrosine kinase inhibitor initiation under Part D.
Impact of Cost Sharing on Specialty Drug Utilization and Outcomes: A Review of the Evidence and Future Directions
March 17, 2016
Article
The authors review published evidence regarding associations between high cost sharing for specialty pharmaceuticals indicated for rheumatoid arthritis, multiple sclerosis, and cancer, and their utilization.
A Randomized Controlled Trial of Negative Co-Payments: The CHORD Trial
September 30, 2015
Article
This study extends value-based insurance design concepts in testing the impact on blood pressure control of rewards that provided negative co-payments for blood pressure medication.
A Randomized Controlled Trial of Co-Payment Elimination: The CHORD Trial
September 30, 2015
Article
This study tests the impact on blood pressure control of a reward that lowered co-payments for blood pressure medication to $0.
Impact of Cost-Sharing on Treatment Augmentation in Patients With Depression
January 16, 2012
Article
Higher patient cost-sharing is associated with a lower likelihood of treatment augmentation in patients with depression who are treated with antidepressants.